Loading data for BMRA — first visit, this takes a few seconds.
Biomerica Inc. (BMRA)
NasdaqCM: BMRA
· Real-Time Price · USD
1.60
+0.04 (2.56%)
At close: Aug 18, 2026, 3:25 PM
Biomerica Inc. (BMRA) Stock Price, Analysis & Data
2.56% (1D)
| Bid | 1.13 |
| Market Cap | 4.94M |
| Revenue (ttm) | 4.33M |
| Net Income (ttm) | -4.17M |
| Beta | 0.31 |
| EPS (ttm) | -1.65 |
| PE Ratio (ttm) | n/a |
| Forward PE | 4.1 |
| P/B (ttm) | 1.46 |
| P/S (ttm) | 1.14 |
| Earnings Date | n/a |
| Ask | 2.04 |
| Volume | 6,210 |
| Avg. Volume (20D) | 11,938 |
| Open | 1.60 |
| Previous Close | 1.56 |
| Day's Range | 1.56 - 1.60 |
| 52-Week Range | 1.45 - 3.60 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About BMRA
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the...
Industry Medical Devices
Sector Healthcare
IPO Date Sep 7, 1984
Employees 53
Stock Exchange NasdaqCM
Ticker Symbol BMRA
Website https://www.biomerica.com
Financial Performance
In 2025, Biomerica's revenue was 5.31M, a decrease of -1.92% compared to the previous year's 5.42M. Earnings were -4.97M, a decrease of -16.81%.
Financial StatementsEarnings Surprise
Biomerica has released their quarterly earnings on Apr 14, 2023:
